论文部分内容阅读
目的:探讨辛伐他汀与低分子肝素钙联合治疗原发性肾病综合征的临床效果。方法:随机戳抽取原发性肾病综合征患者72例,按不同治疗方法将本组分为观察组(n=36例)和对照组(n=36例),观察组患者给予常规激素治疗联合辛伐他汀、低分子肝素钙治疗,对照组患者单纯给予常规激素治疗,对患者治疗效果进行统计对比。结果:观察组有效率明显高于对照组,差异有统计学意义(P<0.05)。结论:对原发性肾病综合征患者采取辛伐他汀与低分子肝素钙联合治疗的疗效较好,促进患者康复,值得临床推荐。
Objective: To investigate the clinical effect of simvastatin combined with low molecular weight heparin in the treatment of primary nephrotic syndrome. Methods: Seventy-two patients with primary nephrotic syndrome were selected randomly by random poking. The patients were divided into the observation group (n = 36) and the control group (n = 36) according to different treatment methods. The patients in the observation group were given conventional steroid therapy Simvastatin, low molecular weight heparin calcium treatment, the control group of patients given conventional hormone therapy, the treatment of patients with statistical comparison. Results: The effective rate of the observation group was significantly higher than that of the control group, the difference was statistically significant (P <0.05). Conclusion: The combination therapy of simvastatin and low molecular weight heparin in patients with primary nephrotic syndrome is more effective and can promote the rehabilitation of patients. It is worth recommending clinically.